Ticker Details
Black Diamond Therapeutics, Inc.
IPO Date:	January 31, 2020
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$147.8M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.34 | 3.65%
Avg Daily Range (30 D):	$0.07 | 3.31%
Avg Daily Range (90 D):	$0.08 | 3.02%

Institutional Daily Volume
Avg Daily Volume:	.74M
Avg Daily Volume (30 D):	.61M
Avg Daily Volume (90 D):	.88M

Trade Size
Avg Trade Size (Sh.):	146
Avg Trade Size (Sh.) (30 D):	134
Avg Trade Size (Sh.) (90 D):	150

Institutional Trades
Total Institutional Trades:	374
Avg Institutional Trade:	$1.82M
Avg Institutional Trade (30 D):	$.52M
Avg Institutional Trade (90 D):	$.8M
Avg Institutional Trade Volume:	.16M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.25M
Avg Closing Trade (30 D):	$.52M
Avg Closing Trade (90 D):	$.86M
Avg Closing Volume:	175.26K

News

Aug 7, 2025 @ 12:23 PM Black Diamond (BDTX) Q2 Loss Narrows 47% Source: Jesterai

Aug 1, 2025 @ 4:21 PM Clarus (CLAR) Q2 Loss Beats Estimates Source: Jesterai

Mar 19, 2025 @ 11:00 AM Servier and Black Diamond Therapeutics AnnounceÂÂ... Source: N/A

Jan 29, 2025 @ 6:00 PM BRAF Inhibitors Market to Register Incremental Gro... Source: Delveinsight

Nov 5, 2024 @ 1:00 PM Black Diamond Therapeutics Reports Third Quarter 2... Source: N/A

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$.39	$-.27	$.39
Diluted EPS	$.39	$-.26	$.39
Revenue	$70M	$M	$70M
Gross Profit
Net Income / Loss	$22.37M	$-15.12M	$22.37M
Operating Income / Loss	$12.52M	$-17.61M	$12.52M
Cost of Revenue
Net Cash Flow	$-15.44M	$-9.87M	$-15.44M
PE Ratio	6.54